FindTrial
Sign In

A patient survey on liver cancer surveillance practices in India

Anonymized patient survey on hepatocellular carcinoma (HCC) surveillance practices in India - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/09/073208
Enrollment
500
Registered
2024-09-02
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C220- Liver cell carcinoma

Interventions

Intervention1: Nil: NA

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Only adult patients more than equal to 18 years. - who speak English Hindi and Marathi - who are receiving a diagnosis and are undergoing evaluation or treatment of HCC at TMH Mumbai will be included.

Exclusion criteria

Exclusion criteria: - Patient not willing for Informed Consent. - Who are Minors

Design outcomes

Primary

MeasureTime frame
- To determine the frequency of prior ultrasound examination, 6-months prior to detection of hepatocellular carcinoma.Timepoint: Baseline—

Secondary

MeasureTime frame
- To determine the stage of hepatocellular carcinoma (Milan criteria) at the time of detection of hepatocellular carcinoma.Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Prachi Patil

Tata Memorial Hospital

prachipatil@gmail.com912224177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026